These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3973822

  • 1. Evaluation of polymeric hydroxamic acid iron chelators for treatment of iron overload.
    Winston A, Varaprasad DV, Metterville JJ, Rosenkrantz H.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):644-9. PubMed ID: 3973822
    [Abstract] [Full Text] [Related]

  • 2. The selection and evaluation of new chelating agents for the treatment of iron overload.
    Pitt CG, Gupta G, Estes WE, Rosenkrantz H, Metterville JJ, Crumbliss AL, Palmer RA, Nordquest KW, Hardy KA, Whitcomb DR, Byers BR, Arceneaux JE, Gaines CG, Sciortino CV.
    J Pharmacol Exp Ther; 1979 Jan; 208(1):12-8. PubMed ID: 759605
    [Abstract] [Full Text] [Related]

  • 3. The development of new iron-chelating drugs.
    Grady RW, Graziano JH, Akers HA, Cerami A.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):478-85. PubMed ID: 1255491
    [Abstract] [Full Text] [Related]

  • 4. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH, Cerny EA, Wright BJ, Rahman YE.
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [Abstract] [Full Text] [Related]

  • 5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 6. Biological evaluation of some ionophore-polymeric chelator combinations for reducing iron overload.
    Tyson CA, LeValley SE, Chan R, Hobbs PD, Dawson MI.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):676-81. PubMed ID: 6707917
    [Abstract] [Full Text] [Related]

  • 7. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N, Buss JL, Soe-Lin S, Felfly H, Trudel M, Ponka P.
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [Abstract] [Full Text] [Related]

  • 8. The development of new iron-chelating drugs. II.
    Grady RW, Graziano JH, White GP, Jacobs A, Cerami A.
    J Pharmacol Exp Ther; 1978 Jun; 205(3):575-65. PubMed ID: 660531
    [Abstract] [Full Text] [Related]

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 10. Iron retention and excretion in mice transfused with homologous or heterologous blood and treated with chelators.
    Gralla EJ, Burgess DH.
    Methods Find Exp Clin Pharmacol; 1982 Apr; 4(3):151-9. PubMed ID: 7121126
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
    Zhou T, Kong XL, Liu ZD, Liu DY, Hider RC.
    Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
    [Abstract] [Full Text] [Related]

  • 12. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
    Hebert C.
    Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
    [Abstract] [Full Text] [Related]

  • 13. Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: synthesis, characterization, and biological evaluation.
    Polomoscanik SC, Cannon CP, Neenan TX, Holmes-Farley SR, Mandeville WH, Dhal PK.
    Biomacromolecules; 2005 Jul; 6(6):2946-53. PubMed ID: 16283713
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [Abstract] [Full Text] [Related]

  • 15. N-phthaloyl-glycine-hydroxamic acid as serum iron chelator in rats.
    Matijević-Sosa J, Samarzija I, Honović L, Jurisić B.
    Acta Pharm; 2008 Jun; 58(2):231-6. PubMed ID: 18515233
    [Abstract] [Full Text] [Related]

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [Abstract] [Full Text] [Related]

  • 18. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
    Yu Y, Wong J, Lovejoy DB, Kalinowski DS, Richardson DR.
    Clin Cancer Res; 2006 Dec 01; 12(23):6876-83. PubMed ID: 17145804
    [Abstract] [Full Text] [Related]

  • 19. Degradation and decolorization of a biodegradable-resistant polymeric dye by chelator-mediated Fenton reactions.
    Arantes V, Baldocchi C, Milagres AM.
    Chemosphere; 2006 Jun 01; 63(10):1764-72. PubMed ID: 16289212
    [Abstract] [Full Text] [Related]

  • 20. Rhodotorulic acid--investigation of its potential as an iron-chelating drug.
    Grady RW, Peterson CM, Jones RL, Graziano JH, Bhargava KK, Berdoukas VA, Kokkini G, Loukopoulos D, Cerami A.
    J Pharmacol Exp Ther; 1979 Jun 01; 209(3):342-8. PubMed ID: 108388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.